Share this article

Led by $1.07bn asset transaction with Lumenis, Israel’s medical devices industry saw a rise of 57.38% in overall deal activity during Q1 2021, when compared with the last four-quarter average, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

A total of 24 deals worth $1.42bn were announced in Q1 2021, compared with the last four-quarter average of 15.25 deals.

venture financing was the leading category in the quarter with 15 deals which accounted for 62.5% of all deals.

In second place was M&A with five deals, followed by private equity with four transactions, respectively accounting for 20.8% and 16.7% of overall deal activity in the Israel’s medical devices industry during the quarter.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData

In terms of value of deals, M&A was the leading deal category in Israel’s medical devices industry with total deals worth $1.13bn, while venture financing and private equity deals totalled $196.5m and $88.4m, respectively.

Israel medical devices industry deals in Q1 2021: Top deals

The top five medical devices industry deals accounted for 88.9% of the overall value during Q1 2021.

The combined value of the top five medical devices deals stood at $1.26bn, against the overall value of $1.42bn recorded for the quarter.

The top five medical devices industry deals of Q1 2021 tracked by GlobalData were:

1) Boston Scientific’s $1.07bn asset transaction with Lumenis

2) The $70m private equity deal with DarioHealth by Driehaus Capital Management, Farallon Capital Management, More Provident Funds, Nantahala Capital Management, Perceptive Advisors, Phoenix Insurance and Pura Vida Investments

3) Insight Partners, Olive Tree Ventures, Qualcomm Ventures, Qumra Capital, Shenzhen Capital Group and Tiger Global Management’s $50m venture financing of TytoCare

4) The $38m venture financing deal with Ibex Medical Analytics by 83North Venture Capital, aMoon Partners, Dell Technologies Capital, Octopus Ventures and Planven Entrepreneur Ventures

5) DarioHealth’s acquisition of Upright Technologies for $31m.